Home | Personnel | Services | Equipment | Sample Preparation | iLab Service Request
|
 |
CHRISTIAN S. HINRICHS, SENIOR FACULTY DIRECTOR Christian S. Hinrichs, MD, joins Rutgers Cancer Institute as Chief of the Section of Cancer Immunotherapy and Co-Director of the Duncan and Nancy MacMillan Cancer Immunology and Metabolism Center of Excellence following his tenure at the National Institutes of Health (NIH). Dr. Hinrichs is a tenured Professor of Medicine at the Rutgers Robert Wood Johnson Medical School, and holds the position of Program Co-leader of the Cancer Metabolism and Growth Program. |
 |
ANKIT SAXENA, PhD, MANAGING DIRECTOR Ankit Saxena, PhD, has received his PhD from All India Institute of Medical Sciences, New Delhi and pursued postdoctoral studies at Johns Hopkins School of Medicine and National Institutes of Health. He holds a Master’s in Business Administration and advance diploma in Bioinformatics. Before coming to Rutgers he was a Staff Scientist at National Heart Lung and Blood Institute Flow Cytometry Shared Resource Lab. He is a certified Flow Cytometrist from ASCP (American Society for Clinical Pathology) and has been actively engaged in assuring quality control, technical troubleshooting and maintenance at NIH Shared Resource lab. With more than 15 years of experience in Flow Cytometry, Cell sorting, Imaging Cytometry and Bead based assays and extensive training in Clinical and Basic Immunology he brings expertise in designing assays, trouble-shooting, operating various Flow Cytometers- Sorters and Analyzers with High throughput systems, AMNIS- Image Cytometer- ISX-II, Bead based assays- Luminex and digital Immunoassays, Multidimensional Data analysis using FlowJo, Cytobank and R based platforms. |
|
EMMANUEL ZACHARIAH, PhD – SCIENTIFIC DIRECTOR Dr. Zachariah received a Ph.D. from the University of Madras, India. He performed Postdoctoral studies at the National University of Singapore and at the Princeton University, and has extensive experience in microarrays, microfluidics, immunodiagnostics, cancer genomics and personalized medicine. Dr. Zachariah has played a key role in developing and providing next-gen DNA sequencing based CLIA tests services in collaboration with RUCDR for personalized medicine applications, and his research interests include development of a novel diagnostic test for the detection of lung cancer in asymptomatic individuals who are at high risk for lung cancer. |
 |
CURTIS KRIER – CORE MANAGER Mr. Krier received a BA from Kutztown University, PA and has over 28 years of research, managerial and clinical laboratory experience at Princeton University, Department of Molecular Biology, Robert Wood Johnson Medical School, RUCDR Infinite Biologics and the Rutgers Cancer Institute of New Jersey. Mr. Krier has extensive experience in the areas of Gene expression, next-generation sequencing, Cancer Genomics and CAP accreditation. |
 |
SHASHI SHARMA – TECHNICIAN Ms. Sharma received a BS with Honors from Delhi University and an MS with Honors from Panjab University in microbiology. She completed a second MS in Biotechnology at Kean University, completing her thesis in cancer research at Nelson Biological Laboratories at Rutgers University. In her time at CINJ, she has worked in Cancer Pharmacology and the Phase 1 clinical trial development of therapeutics in hematology oncology. Ms. Sharma’s research interests include challenges in pseudo progression evaluation during immune checkpoint blockade, ligand-receptor interactions in the tumor microenvironment, and the role of tumor cells in the mediation of immune suppression. Contact: shashi.sharma@rutgers.edu |